Pharmaceutical & Life Sciences

If you can't find what you want, Ask Us.

Refine Your Results


Filter by Category




Showing 1041-1048 of 1048 results Sort by:


  • 1041 Request Info

    Understanding ISO 13485 and its Relation to FDA's Quality Systems Regulation by Jessica Czamanski

    Areas Covered in the Webinar: Concept of quality management system All clauses in ISO 13485 Auditable clauses of ISO 13485 All parts of the FDA’s QSR Who is responsible for complying with QSR Differences between ISO 13485 and QSR Role of management in quality Exclusions from specific parts of the regulation or standard Internal audit requirement Who Will Benefit: Medical device manufacturers R&D teams for medical devices Personnel involved in the packaging of medical devices and packaging engineers Inventory control personnel in a medical device company Quality personnel and quality engineers Suppliers to medical device companies Biomedical engineers Manufacturing engineers
  • 1042 Request Info

    Verification vs. Validation in Regulated Industries by John Chapman

    Areas Covered in the Webinar: Verification & validation types. Definitions. Design control. Process control. Application. Consequences of poor verification & validation. Why verification & validation makes good business sense?
  • 1043 Request Info

    Medical Device Risk Management A to Z - Best Practices for Effectiveness and Efficiency by Dr. Harvey Rudolph, HRRM, LLC (Ex-FDA Official, ISO 14971 S

    Learning Objectives: To educate attendees on the vital reasons for risk management and the key role it plays in the product life cycle To demonstrate the requirements of ISO 14971, how they reflect FDA concerns To clarify how risk management impacts international standards, such as IEC 60601, and how to conform to risk management requirements To provide practical application experience and skills in the process and tools of risk management, enabling attendees to be effective risk managers To teach how to establish a quantitative risk management system and one that complies with EN/ISO 14971:2012 To provide attendees with the Dos and Don'ts for an effective and efficient risk management system.
  • 1044 Request Info

    How to Prepare for, Manage, and Follow-up to an FDA Inspection: Risk-driven Approach: One and a Half day In-Person Seminar

    The FDA inspection is one of the critical measures of your quality system and your organization as a whole. Since a perfect quality system is usually not implemented, the preparation for and management of an FDA inspection is critically important. A well-established quality system provides a solid foundation for passing FDA inspections; however, if you don’t proactively examine your quality system from the perspective of a FDA inspector, you can still have difficulties. Note: Use coupon code 232082 and get 10% off on registration.
  • 1045 Request Info

    FDA's New Import Program for 2019 - Strict Precision:2-Day In-Person Seminar by Ex-FDA Official

    You will be able to answer the following questions with this course without saying, “I don’t know?” What are the FDA’s import legal requirements and policy? How do you deal with the FDA and the U.S. Customs and Border Patrol procedures? What happens when your product is detained? What happens if a foreign manufacturer is in trouble with the FDA? How do you inter-act with the FDA to work out problems? Why are import and export rules different or does it even matter? Seminar Instructor Casper Uldriks is an "Ex-FDA Official" who has spent 32 years in FDA and his engagements focus on advertising and promotion, recalls, corrections and removals and enforcement. He currently trains FDA personnel and counsels clients on wide range of topics, including: FDA inspections; import operations; advertising and promotion; corrective and preventive actions; medical device reporting and corporate reorganization to improve conformance to the FDA’s requirements.
  • 1046 Request Info

    FDA's Refuse to Accept Policy - How to Prepare 510 (K) Submission to Avoid the Pitfalls of the Policy

    Learning Objectives Upon completing this course participants will understand: Difference between a traditional, abbreviated and special 510(k) and when to submit each type of 510(k) When to file for a new device, a change in the intended use or a change in the technology of a cleared device What is contained in a traditional, abbreviated and special 510(k) submission package The submission package, user fees and making an eCopy What is substantial equivalence and what’s required to show substantial equivalence What’s required on the labeling and IFU Which performance tests should be conducted and how to present the data to the FDA The requirements for a risk management plan and report Understand the FDA’s Refuse to Accept Policy What is required in a submission for software controlled devices How and when to use third party reviews When clinical data may be required.
  • 1047 Request Info

    Manufacturing and Marketing Cosmeceutical* and Homeopathic OTCs: Complying with FDA's Rules for Drug Products that do not require FDA Pre-App

    Understand FDA rules and policies regarding manufacturing and labeling of low risk OTC drugs not covered by approved New Drug Applications. Learn the definitions of drug, cosmetic, dietary supplement. Understand how labeling other than labels and advertising can define a product and cause it to be misbranded or considered a new drug. Differentiate cosmetic “puffery" claims from claims that FDA would likely consider drug claims. Understand the differences between allopathic (conventional) drugs and homeopathic drugs. Recognize ways to manufacture low health risk products at minimum cost, yet still meet the intent and basic requirements of GMP regulations. Learn how to minimize the regulatory risk of a Warning Letter or other FDA action.
  • 1048 Request Info

    Post-Market Compliance for Medical Devices and Evolving Reporting Requirements: Complaint Handling, MDR/eMDR and Recalls including UDI update

    This interactive one and a half day course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief, who has more than 36 years’ experience with the FDA will provide the participants tools to minimize risk of regulatory enforcement actions. Learning Objectives: Understand how to comply with complicated Compliant Handling, MDR and Recall requirements. Firms MDR reporting and FDA's handling of reports. Company preparation in the event of a Recall, recall strategy, notification letter and communicating with the FDA. Who will Benefit: This course will benefit anyone in the medical device industry that handles functions involving product complaints, recalls, medical device reporting. Regulatory Affairs QA/QC Project Managers Regulatory Professional Risk Managers Note: Use coupon code NB5SQH8N and get 10% off on registration.